EphA3 couples attractive guidance to persistent retinal axon growth through modulation of EphA4 forward signaling in a plasma membrane cholesterol-dependent manner

The brain is a vast network of wires, but unlike the copper cables in a wall, these biological connections must find their way across the body with pinpoint accuracy during development. In the visual system, nerve cells in the eye, known as retinal ganglion cells, send long fibers called axons to a specific target in the brain. For vision to work, these fibers must map the world exactly as it is: the left side of the eye must connect to the right side of the brain, and the top must connect to the bottom. If these wires cross over or stop in the wrong place, the result is blindness or distorted sight. To achieve this, growing axons rely on chemical signposts in their environment. Some of these signs tell the axon to stop, while others tell it to turn or keep moving forward. For decades, scientists understood that a specific family of proteins, called EphA receptors and their partners, ephrins, act as a major set of these signposts, often functioning as a repulsive force that pushes axons away from areas where they do not belong. However, the full story of how these signals guide an axon not just away from danger, but actively toward its destination while keeping it moving, has remained incomplete.

A team of researchers at the University of Buenos Aires and Miami University has now uncovered a more nuanced role for these proteins, revealing how they can act as a gentle hand guiding a nerve fiber forward rather than just a wall pushing it back. Focusing on the nasal part of the chicken eye, which sends axons to the back of the brain target, the scientists investigated how a specific protein, EphA3, influences the behavior of these growing nerves. They discovered that when EphA3 is present on the surface the axon is walking on, it does not repel the nerve. Instead, it attracts it, pulling the axon toward higher concentrations of the protein. More importantly, this attraction does more than just change direction; it helps the axon keep moving steadily without stopping or backing up. The researchers found that this process relies on two critical factors: the axon must have a baseline level of activity from a related protein called EphA4, and the outer membrane of the nerve cell must be rich in cholesterol, a fatty substance that helps organize the cell's surface.

To see how this works, the scientists grew retinal nerve cells in a dish and placed them on a surface patterned with alternating stripes of the EphA3 protein and a control substance. They observed that the nasal axons consistently chose to grow on the stripes containing EphA3, ignoring the control areas. This confirmed that the protein acts as a magnet for these specific nerve fibers. To understand the mechanics of this attraction, the team then placed the cells in a chamber where the EphA3 protein formed a smooth gradient, rising in concentration from one side to the other. Using time-lapse cameras to watch the axons grow over two hours, they saw the nerve tips turning toward the source of the protein. The turning was not random; the axons actively steered themselves up the chemical slope.

The study went deeper to measure how the axons moved during this journey. The researchers tracked the speed and behavior of the growth cones, the tips of the axons that explore the environment. They found that the presence of EphA3 did not make the axons move at their absolute fastest possible speed. Instead, it changed the rhythm of their movement. Under normal conditions, growing axons often pause, stop, or even pull back slightly before moving forward again. When exposed to EphA3, the axons spent significantly more time in a continuous forward motion and far less time pausing or retracting. The protein essentially smoothed out the journey, allowing the axon to maintain a steady pace for longer periods. This suggests that EphA3 helps the nerve fiber commit to its path, reducing the hesitation that often slows down growth.

However, this attractive guidance is not a simple on-off switch. The researchers discovered that the axon's ability to respond to EphA3 depends on the activity of another protein, EphA4, which is naturally present on the nerve cell. When the scientists used a drug to block EphA4 completely, the axons lost their ability to turn toward the EphA3 signal. They grew just as fast, or even faster, but they wandered aimlessly, no longer following the chemical map. This finding rules out the idea that EphA3 works in isolation; instead, it requires a specific, moderate level of EphA4 activity to function correctly as a guide. It appears that EphA4 acts as a necessary partner that allows the axon to interpret the EphA3 signal and translate it into a directional turn.

The study also highlighted the importance of the physical structure of the nerve cell's outer membrane. The researchers treated the cells with a substance that removes cholesterol from the membrane, effectively disrupting the lipid rafts—specialized patches on the cell surface where these signaling proteins gather. When cholesterol was depleted, the axons grew more slowly and stopped more frequently. Crucially, the attractive pull of EphA3 vanished. The axons no longer turned toward the protein, and the steady, persistent growth it usually encouraged disappeared. This indicates that the cholesterol-rich environment is essential for the EphA3 and EphA4 proteins to interact properly and send the correct signals to the cell's internal machinery.

By combining these observations, the researchers proposed a model for how the brain builds its visual map. In the developing brain, the target area contains a gradient of EphA3, with high levels where nasal axons enter the rostral tectum. Nasal axons, which need to reach the back, are attracted to this high concentration. The presence of EphA3 attracts the axon and keeps it moving forward steadily, preventing it from stopping too early or branching off in the wrong place. As the axon travels further into the target area, the levels of EphA3 drop, and other signals take over to slow the growth and encourage the axon to stop and form connections. The study suggests that if EphA4 is blocked entirely, the axon might grow very fast and continue past its target, potentially ruining the map. Conversely, if the membrane cholesterol is disrupted, the axon cannot read the map at all.

This work clarifies that guidance is not just about avoiding the wrong places; it is an active process of steering and sustaining growth. The findings show that the same family of proteins can act as both a repulsive barrier and an attractive guide, depending on the context and the specific partners they interact with. The research underscores that the physical state of the cell membrane, specifically its cholesterol content, is a fundamental requirement for these complex navigational tasks. By showing how EphA3 couples directional turning with persistent forward growth, the study provides a clearer picture of the delicate balance required for the brain to wire itself correctly. It suggests that successful regeneration of nerve fibers in the future may require not just stimulating growth, but also ensuring that the guidance signals and the membrane environment are intact to keep those fibers on the right path.